Stay updated on Efficacy Safety Tislelizumab Fruquintinib Combo Clinical Trial
Sign up to get notified when there's something new on the Efficacy Safety Tislelizumab Fruquintinib Combo Clinical Trial page.

Latest updates to the Efficacy Safety Tislelizumab Fruquintinib Combo Clinical Trial page
- Check7 days agoNo Change Detected
- Check14 days agoChange DetectedFooter now displays Revision: v3.4.2 and the older government funding/operating status notices (v3.4.1) have been removed.SummaryDifference0.4%

- Check21 days agoChange DetectedNotice about a lapse in government funding and the NIH Clinical Center's operating status added; site revision updated from v3.4.0 to v3.4.1. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.4%

- Check28 days agoChange DetectedUI and metadata updates include a glossary toggle, a new label 'Last Update Submitted that Met QC Criteria' for QC status, capitalization changes for 'No FEAR Act Data', and a new page revision indicator 'Revision: v3.4.0'. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.2%

- Check35 days agoChange DetectedThe page shows a revision update from v3.3.3 to v3.3.4. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.0%

- Check64 days agoChange DetectedAdded new study locations: Fujian, Gansu, Heilongjiang, Henan, Shandong, Sichuan, Tianjin Municipality, Zhejiang (China) and Gyeonggi-do, Seoul Teugbyeolsi (South Korea). Updated revision tag from v3.3.2 to v3.3.3.SummaryDifference1%

- Check85 days agoChange DetectedRevision tag updated from v3.3.1 to v3.3.2 on the page, with no changes to study details or content. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.0%

Stay in the know with updates to Efficacy Safety Tislelizumab Fruquintinib Combo Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Efficacy Safety Tislelizumab Fruquintinib Combo Clinical Trial page.